Understanding the complex interactions in the tumor microenvironment (TME) plays a pivotal role in the onset of cancer, the advancement of tumors, and the determination of the reaction against anti-cancer treatments.
Traditional studies fail to recognize the potential of studying the spatial arrangement of the TME and are therefore unable to completely uncover its intricacies. To overcome these limitations, we use quantitative image analysis based on multiplex immunohistochemistry to extract data from the TME.
Discover how our proprietary imaging platform helps identify drug targets in spatial environments and provides insights into treatment response for non-small cell lung cancer.